Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study

European Huntington's Disease Network

Research output: Contribution to journalArticlepeer-review

Fingerprint

Dive into the research topics of 'Safety and efficacy of pridopidine in patients with Huntington's disease (PRIDE-HD): a phase 2, randomised, placebo-controlled, multicentre, dose-ranging study'. Together they form a unique fingerprint.

Medicine & Life Sciences